Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-02-19 @ 6:46 AM
Study NCT ID:
NCT07272135
Status:
COMPLETED
Last Update Posted:
2025-12-09
First Post:
2022-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selective β2-AR Antagonism in Asthma
Sponsor:
Trio Medicines Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
T-030
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |